VXR 107 (Venlafaxine Hydrochloride Extended-Release 150 mg)
Pill with imprint VXR 107 is Red, Capsule-shape and has been identified as Venlafaxine Hydrochloride Extended-Release 150 mg. It is supplied by Orchid Healthcare.
Venlafaxine is used in the treatment of autism; anxiety; major depressive disorder; depression; generalized anxiety disorder and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Venlafaxine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for VXR 107
Venlafaxine Hydrochloride Extended-Release
- Imprint
- VXR 107
- Strength
- 150 mg
- Color
- Red
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Serotonin-norepinephrine reuptake inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Orchid Healthcare
- National Drug Code (NDC)
- 68820-0107
More about venlafaxine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 2317 Reviews
- Drug class: serotonin-norepinephrine reuptake inhibitors
- FDA Alerts (5)
Consumer resources
- Patient Information
- Venlafaxine (Advanced Reading)
- Venlafaxine Extended-Release Tablets
- Venlafaxine Tablets
- Venlafaxine Extended-Release Capsules
- Other brands
- Effexor, Effexor XR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.